skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metallothionein as a compensatory component prevents intermittent hypoxia-induced cardiomyopathy in mice

Journal Article · · Toxicology and Applied Pharmacology
;  [1];  [1];  [2];  [3];  [2];  [4];  [2];  [2];  [2]
  1. The First Hospital of Jilin University, Changchun, 130021 (China)
  2. KCHRI at the Department of Pediatrics, School of Medicine, University of Louisville, Louisville, 40202 (United States)
  3. Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY 40202 (United States)
  4. Department of Medicine, School of Medicine, University of Louisville, Louisville, 40202 (United States)

Obstructive sleep apnea (OSA) causes chronic intermittent hypoxia (IH) to induce cardiovascular disease, which may be related to oxidative damage. Metallothionein (MT) has been extensively proved to be an endogenous and highly inducible antioxidant protein expressed in the heart. Therefore, we tested the hypotheses that oxidative stress plays a critical role in OSA induced cardiac damage and MT protects the heart from OSA-induced cardiomyopathy. To mimic hypoxia/reoxygenation events that occur in adult OSA patients, mice were exposed to IH for 3 days to 8 weeks. The IH paradigm consisted of alternating cycles of 20.9% O{sub 2}/8% O{sub 2} F{sub I}O{sub 2} (30 episodes per hour) with 20 s at the nadir F{sub I}O{sub 2} for 12 h a day during daylight. IH significantly increased the ratio of heart weight to tibia length at 4 weeks with a decrease in cardiac function from 4 to 8 weeks. Cardiac oxidative damage and fibrosis were observed after 4 and 8 weeks of IH exposures. Endogenous MT expression was up-regulated in response to 3-day IH, but significantly decreased at 4 and 8 weeks of IH. In support of MT as a major compensatory component, mice with cardiac overexpression of MT gene and mice with global MT gene deletion were completely resistant, and highly sensitive, respectively, to chronic IH induced cardiac effects. These findings suggest that chronic IH induces cardiomyopathy characterized by oxidative stress-mediated cardiac damage and the antioxidant MT protects the heart from such pathological and functional changes. - Highlights: • The effect of intermittent hypoxia (IH) on cardiac metallothionein (MT) • Cardiac MT expression was up-regulated in response to 3-day IH. • Exposure to 4- or 8-week IH downregulated cardiac MT expression. • Overexpression of cardiac MT protects from IH-induced cardiac damage. • Global deletion of MT gene made the heart more sensitive to IH damage.

OSTI ID:
22439715
Journal Information:
Toxicology and Applied Pharmacology, Vol. 277, Issue 1; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: Role of oxidative stress and apoptosis
Journal Article · Sun May 15 00:00:00 EDT 2011 · Toxicology and Applied Pharmacology · OSTI ID:22439715

ALDH2 restores exhaustive exercise-induced mitochondrial dysfunction in skeletal muscle
Journal Article · Sat Apr 15 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22439715

p21{sup WAF1/Cip1/Sdi1} knockout mice respond to doxorubicin with reduced cardiotoxicity
Journal Article · Tue Nov 15 00:00:00 EST 2011 · Toxicology and Applied Pharmacology · OSTI ID:22439715